Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review Follow us on Twitter
Join us on LinkedIn

The NanoRam™ is a state-of-the-art compact Raman handheld spectrometer and integrated computing system for material identification and verification within cGMP compliant facilities. Designed for use by non-specialists, the NanoRam is easy to use and operates single-handedly, weighing less than 2.2lbs. It allows rapid development of standardized and validated methods to facilitate inspection for purity and quality, making it the ideal choice for pharmaceutical, chemical, and material identification, whether in the lab, the warehouse, the loading dock or the field.  The NanoRam is the only handheld Raman device that features a temperature controlled detector, providing superior data quality and unprecedented system stability. Coupling this proprietary thermoelectric cooling with our patented CleanLaze® laser stabilization technology and high speed micro-processor, it provides laboratory performance in the palm of your hand. The first rate signal reduces the need for further testing, therefore decreasing production costs and escalating productivity, all at the same time.

www.nanoram.com

Featured whitepaper

Whitepaper: New Support for ISO 14644-1
Author: HACH LANGE
Changes in ISO 14644-1 to improve confidence in quality for critical life-science applications. Tony Harrison, UK Subject Matter Expert to ISO TC209 Working Group.

Whitepapers also available for download:

Increase the Physiological Relevance of HIV Models with RoboSep™
Author: STEMCELL Technologies

A comparison of the attributes of the AccuGENX-ID microbial sequencing methods versus MicroSEQ v2.0
Author: Accugenix

Autoantibody biomarker panels for improved disease diagnosis
Author: Oxford Gene Technology

Utilizing Colony-Forming Cell Assays In Toxicity Testing
Author: STEMCELL Technologies

An Interview with Dr. John Rossi
Author: Integrated DNA Technologies

RNA-Seq Data Comparison with Gene Expression Microarrays
Author: illumina

The importance of being profiled: Improving drug candidate safety and efficacy using cross-target profiling
Author: Merck Millipore

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- B&W Tek, Inc.
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- CAMO Software AS
- Catalent Pharma Solutions
- CI Precision
- EMD Millipore
- Expo Technologies, LLC.
- GE Analytical Instruments
- HACH LANGE GMBH
- I Holland Limited
- Lonza
- Merck Millipore
- Patheon Inc
- Peter Huber Kältemaschinenbau
- Porvair Sciences Ltd
- Randox Pharma Services
- Rapid Micro Biosystems
- Realia

Add your company here

Academia-pharma collaboration attracts GBP14.4 million funding in the UK to accelerate drug discovery

The University of Dundee and the Medical Research Council have announced new funding of over GBP14 million from a consortium of six pharmaceutical companies for continuing research on the development of new drug treatments for major global diseases.

The consortium, called the Division of Signal Transduction Therapy (DSTT), includes AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Janssen Pharmaceutica NV, Merck-Serono and Pfizer...

Read the full story >>

  Division of Signal Transduction Therapy logos

More pharmaceutical & life science news

Daiichi Sankyo and the National Cancer Center form comprehensive research alliance
This agreement is designed to integrate the high-level cancer research technology...

FDA approves new labeling for ISENTRESS® (raltegravir)
The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study...

Capital increase in Lundbeck as a result of employee warrant programme
Lundbeck increases its share capital by 593 shares as a result of employee warrant exercise...

Two overall winners announced at prestigious national award ceremony in London’s Science Museum
Judges of the GSK IMPACT Awards could not choose one overall winner for the awards...

New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine
Use of biomarker has potential to advance personalised treatment for MS patients...

NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN)
Janssen Pharmaceuticals announce results of an investigational Phase 3 study...

Pfizer exploratory study measures effects of Lyrica (pregabalin) on brain activity in fibromyalgia patients
Results of studies on Lyrica® announced...

GSK statement on tender offer to acquire Human Genome Sciences
GSK believes its offer represents full and fair value and is in the best interests of both companies’ shareholders...

ArQule and Daiichi Sankyo announce completion of patient recruitment in Phase 3 clinical trial of Tivantinib in non-small cell lung cancer
ArQule and Daiichi Sankyo announced that recruitment of patients has been completed...

Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients
Results from pivotal Phase III GLOW2 study...

Amgen’s BiTE® Antibody Blinatumomab achieved high rate of complete response in adult patients with relapsed or refractory acute lymphoblastic leukemia
Updated results from a Phase 2 study...

analytica 2012 - Exclusive video interviews

B&W Tek interviewed at analytica 2012
Enrique Lozano Diz, Global Product Manager at B&W Tek, inc speaks to European Pharmaceutical Review at analytica 2012.

Waters interviewed at analytica 2012
Erik Junius, Director Informatics Europe at Waters speaks to Freddy White, Director of the European Pharmaceutical Review at analytica 2012.

Protea interviewed at analytica 2012
Alessandro Baldi, VP and General Manager at Protea speaks to Freddy White, Director of the European Pharmaceutical Review at analytica 2012.

AnalytikJena interviewed at analytica 2012
Andrea Glomb, General Manager International Sales, AnalytikJena speaks to Freddy White, Director of the European Pharmaceutical Review at analytica 2012.

Charles River Laboratories at analytica 2012
Yvonne Boss, European In-Vitro Specialist Sales Manager at Charles River Laboratories speaks to European Pharmaceutical Review at analytica 2012.

Conferences, events & exhibitions:

International Conference on Genomics
24 - 26 May 2012, Copenhagen, Denmark

FCE Pharma
29 - 31 May 2012, Sao Paulo, Brazil

European Lab Automation 2012
30 - 31 May 2012, Hamburg, Germany

Life Science User Group
7 June 2012, San Juan, Puerto Rico

BPS Focused Meeting on Neuropeptides
7 - 9 June 2012, London, UK

13th Drug Discovery Summit 2012
11 - 12 June 2012, Zurich, Switzerland

Pharma R&D Europe Summits
11 - 12 June 2012, Zurich, Switzerland

2. Laupheimer Zelltage
11 - 12 June 2012, Laupheim, Germany

Life Science User Group
12 June 2012, Missouri, USA

ISSCR 2012
13 - 16 June 2012, Yokohama, Japan

Life Science User Group
14 June 2012, Indiana, USA